Skip to main content
. Author manuscript; available in PMC: 2022 May 26.
Published in final edited form as: Mol Cancer Res. 2021 Jan 29;19(5):913–920. doi: 10.1158/1541-7786.MCR-20-0738

Figure 6: Gilteritinib inhibits the clonogenic potential of ALCL cells.

Figure 6:

DEL and SU-DHL-1 cells were treated with indicated concentrations of gilteritinib for 24 hours, washed, mixed with MethoCult medium, and plated. After eight days of incubation, the number of colonies were counted. Columns represent the mean of three independent experiments; bars represent the SEM.